Luo C, Luo S, Wusimanjiang W, Wang Z, et al. Bladder-sparing treatment using tislelizumab combined with gemcitabine/cisplatin in selected patients with muscle-invasive bladder cancer: a real-world study. Clin Transl Oncol 2024 Mar 12. doi: 10.1007/s12094-024-03400.
PMID: 38472556